44
Participants
Start Date
May 1, 2025
Primary Completion Date
August 30, 2025
Study Completion Date
September 30, 2025
Shatavari Root Extract, oral capsule
"This intervention consists of a proprietary, standardized extract of Asparagus racemosus (Shatavari), formulated specifically for women's health and cognitive support. The supplement is provided in oral capsule form and standardized to a specific concentration of shatavarin IV, the primary active compound. Participants will take one capsule daily for 30 days.~This formulation, known as SheVari4™, is patent-pending and manufactured by Cepham, designed to address vasomotor symptoms (hot flashes) and other menopausal concerns. It is distinct from other Shatavari supplements in its standardization and use in a placebo-controlled, double-blind trial targeting postmenopausal women."
Jacksonville University, Jacksonville
Jacksonville University
OTHER